SALUBRIS
Live / Registered — International registration cancelled — extension of protection cancelled (as of 12 May 2020)
What this means for you
Registered since 07 Jun 2011. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79083827
- Registration number
- 3972681
- Mark type
- Word mark
- Filed
- 11 May 2010
- Published for opposition
- 22 Mar 2011
- Registered
- 07 Jun 2011
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, for treating diseases of cardiovascular system, for use in hematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; chemico-pharmaceutical preparations, namely, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; chemical preparations for pharmaceutical purposes, namely, for treating diseases of cardiovascular system, for use in hematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; medicines for human purposes, namely, for treating diseases of cardiovascular system, for use in hematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; troches, namely, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; pharmaceutical products, namely, active pharmaceutical ingredients which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; prepared Chinese medicines, namely, for treating diseases of cardiovascular system, for use in hematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; biochemical medicines, namely, for treating diseases of cardiovascular system, for use in hematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; dietetic substances adapted for medical use, namely, beverages or food which are used for treating diseases of cardiovascular system, for use in hematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; capsules for pharmaceutical purposes containing pharmaceutical preparations, specifically for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; drugs for medical purposes, namely, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases
Owner
- SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD, SHENZHEN, CN
- SHENZHEN SALUBRIS PHARMACEUTICALS; CO., LTD, CN
- SHENZHEN SALUBRIS PHARMACEUTICALS; CO.,LTD, SHENZHEN, CN
Prosecution history
- 04 Dec 2020 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 04 Dec 2020 — DEATH OF INTERNATIONAL REGISTRATION
- 27 Sept 2019 — TOTAL INVALIDATION PROCESSED BY THE IB
- 01 Jul 2019 — GENERIC MADRID TRANSACTION SENT TO IB
- 01 Jul 2019 — GENERIC MADRID TRANSACTION CREATED
- 12 Jun 2019 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 12 Oct 2018 — CANCELLED SECTION 71
- 10 Oct 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Jan 2018 — POST REGISTRATION ACTION MAILED - SEC.71
- 19 Dec 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Dec 2017 — TEAS SECTION 71 RECEIVED
- 06 Dec 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Feb 2013 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 01 Nov 2011 — FINAL DISPOSITION NOTICE SENT TO IB
- 07 Sept 2011 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB